On January 10, the Tianjin Medical Procurement Center announced that MSD's COVID-19 oral drug Molnupiravir Capsules had been listed on the platform, with an initial price of 1500 yuan per bottle.
Merck's COVID-19 Oral Drug Molnupiravir Capsules Listed in Tianjin Procurement Platform at RMB 1,500 per Bottle
Jan 10, 2023 21:31
CST Updated
21:31
MSD
Pharmaceutical R&D and Manufacturer